Yirong Sim

680 total citations
27 papers, 292 citations indexed

About

Yirong Sim is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, Yirong Sim has authored 27 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 12 papers in Oncology and 9 papers in Surgery. Recurrent topics in Yirong Sim's work include Breast Cancer Treatment Studies (14 papers), Breast Lesions and Carcinomas (9 papers) and Global Cancer Incidence and Screening (7 papers). Yirong Sim is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Breast Lesions and Carcinomas (9 papers) and Global Cancer Incidence and Screening (7 papers). Yirong Sim collaborates with scholars based in Singapore, United Kingdom and Switzerland. Yirong Sim's co-authors include Robin F. Irvine, Gerald Hammond, Leon Lagnado, Benita Kiat Tee Tan, Veronique Kiak Mien Tan, Preetha Madhukumar, Wei Sean Yong, Kong Wee Ong, Chow Yin Wong and Fuh Yong Wong and has published in prestigious journals such as Nature Communications, The Journal of Cell Biology and Scientific Reports.

In The Last Decade

Yirong Sim

25 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yirong Sim Singapore 11 99 94 83 71 50 27 292
Éric Lifrange Belgium 10 141 1.4× 86 0.9× 112 1.3× 84 1.2× 58 1.2× 27 345
Anca Chelariu-Raicu Germany 12 87 0.9× 142 1.5× 179 2.2× 27 0.4× 32 0.6× 42 434
Feng Yao China 12 183 1.8× 178 1.9× 204 2.5× 25 0.4× 52 1.0× 22 468
Christopher Farrell United States 8 70 0.7× 70 0.7× 131 1.6× 22 0.3× 36 0.7× 27 272
Cassandra L. Sather United States 9 133 1.3× 83 0.9× 176 2.1× 96 1.4× 41 0.8× 13 409
Shizuo Machida Japan 13 37 0.4× 117 1.2× 136 1.6× 46 0.6× 29 0.6× 30 466
Xiantao Sun China 13 162 1.6× 66 0.7× 258 3.1× 34 0.5× 43 0.9× 28 436
Antonio Fernández‐Suárez Spain 11 40 0.4× 55 0.6× 75 0.9× 52 0.7× 48 1.0× 34 304
Antônio Luiz Frasson Brazil 10 166 1.7× 75 0.8× 39 0.5× 72 1.0× 116 2.3× 44 304
Diederik Wehkamp Netherlands 7 74 0.7× 69 0.7× 88 1.1× 24 0.3× 29 0.6× 11 272

Countries citing papers authored by Yirong Sim

Since Specialization
Citations

This map shows the geographic impact of Yirong Sim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yirong Sim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yirong Sim more than expected).

Fields of papers citing papers by Yirong Sim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yirong Sim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yirong Sim. The network helps show where Yirong Sim may publish in the future.

Co-authorship network of co-authors of Yirong Sim

This figure shows the co-authorship network connecting the top 25 collaborators of Yirong Sim. A scholar is included among the top collaborators of Yirong Sim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yirong Sim. Yirong Sim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Carter, Jean-Michel, et al.. (2024). TWEAK/Fn14 signalling driven super-enhancer reprogramming promotes pro-metastatic metabolic rewiring in triple-negative breast cancer. Nature Communications. 15(1). 5638–5638. 9 indexed citations
3.
Tan, Veronique Kiak Mien, Benita Kiat Tee Tan, Yirong Sim, et al.. (2023). Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers. npj Breast Cancer. 9(1). 84–84. 2 indexed citations
4.
Lim, Hui Jun, Lester Chee Hao Leong, Eugene Ong, et al.. (2023). Savi Scout® wireless localisation of breast and axillary lesions: lessons learned from Singapore’s early experience. Singapore Medical Journal. 67(Suppl 2). S119–S123. 1 indexed citations
5.
Sim, L.S.J., et al.. (2023). Breast metastasis from endometrial clear cell carcinoma: A case report and review of the literature. Frontiers in Oncology. 12. 1070744–1070744. 3 indexed citations
6.
Sim, Yirong, Cindy Lim, Benita Kiat Tee Tan, et al.. (2022). The Impact of Statin Use and Breast Cancer Recurrence - A Retrospective Study in Singapore. Frontiers in Oncology. 12. 835320–835320. 14 indexed citations
7.
Tan, Puay Hoon, Veronique Kiak Mien Tan, Benita Kiat Tee Tan, et al.. (2022). Atypical Ductal Hyperplasia of the Breast on Core Needle Biopsy: Risk of Malignant Upgrade On Surgical Excision. Journal of Breast Cancer. 25(1). 37–37. 4 indexed citations
8.
Ho, Peh Joo, Rajkumar Dorajoo, Alexis Jiaying Khng, et al.. (2021). DNA methylation and breast cancer-associated variants. Breast Cancer Research and Treatment. 188(3). 713–727. 5 indexed citations
9.
Lim, Sue Zann, Grace Kusumawidjaja, Benita Kiat Tee Tan, et al.. (2021). Outcomes of Stage I and II Breast Cancer with Nodal Micrometastases Treated with Mastectomy without Axillary Therapy. Breast Cancer Research and Treatment. 189(3). 837–843. 7 indexed citations
10.
Wong, Fuh Yong, Siqin Zhou, Whee Sze Ong, et al.. (2020). Effects of housing value and medical subsidy on treatment and outcomes of breast cancer patients in Singapore: A retrospective cohort study. The Lancet Regional Health - Western Pacific. 6. 100065–100065. 10 indexed citations
11.
Ho, Peh Joo, Samuel G.W. Ow, Yirong Sim, et al.. (2020). Impact of deviation from guideline recommended treatment on breast cancer survival in Asia. Scientific Reports. 10(1). 1330–1330. 13 indexed citations
12.
Koh, Jin‐Young, Cedric Chuan Young Ng, L. J. Wei, et al.. (2020). 57P Therapeutic vulnerability of malignant phyllodes tumour to pazopanib identified through a novel patient-derived xenograft and cell line model. Annals of Oncology. 31. S1264–S1264.
13.
Chan, Jack Junjie, Yirong Sim, Samuel G.W. Ow, et al.. (2020). The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience. Endocrine Related Cancer. 27(9). R307–R327. 25 indexed citations
14.
Sim, Yirong, Cedric Chuan Young Ng, Vikneswari Rajasegaran, et al.. (2019). A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions. BMC Medical Genomics. 12(1). 21 indexed citations
15.
Sim, Yirong, Kong Wee Ong, Wei Sean Yong, et al.. (2018). Surgical and oncological safety of nipple-sparing mastectomy in an Asian population. Breast Cancer. 26(2). 165–171. 6 indexed citations
16.
Zheng, Huili, Tira J. Tan, Ravindran Kanesvaran, et al.. (2017). Surgery for early breast cancer in the extremely elderly leads to improved outcomes – An Asian population study. The Breast. 36. 44–48. 14 indexed citations
17.
Tan, Veronique Kiak Mien, Wei Sean Yong, Chow Yin Wong, et al.. (2016). Trends in Post-Mastectomy Reconstruction in an Asian Population: A 12-Year Institutional Review. The Breast Journal. 23(1). 59–66. 15 indexed citations
18.
Sim, Yirong, et al.. (2013). Primary melanoma of the esophagus, a diagnostic challenge. Asian Journal of Surgery. 38(4). 236–238. 4 indexed citations
19.
Sim, Yirong, Fabian Yap, Khee Chee Soo, & Yee Low. (2013). Medullary thyroid carcinoma in ethnic Chinese with MEN2A: A case report and literature review. Journal of Pediatric Surgery. 48(1). e43–e46. 3 indexed citations
20.
Brough, David, Yirong Sim, Peter Thorn, & Robin F. Irvine. (2005). The structural integrity of the endoplasmic reticulum, and its possible regulation by inositol 1,3,4,5-tetrakisphosphate. Cell Calcium. 38(2). 153–159. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026